Bausch Health Companies (BHC) Stock Forecast & Price Target

$5.99

+0.11 (+1.87%)

(As of 07/26/2024 ET)

Bausch Health Companies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 5 Analyst Ratings

Based on 5 Wall Street analysts who have issued ratings for Bausch Health Companies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 4 have given a hold rating, and 1 has given a buy rating for BHC.

Consensus Price Target

$9.80
63.61% Upside

High Forecast	$14.00
Average Forecast	$9.80
Low Forecast	$7.00

According to the 5 analysts' twelve-month price targets for Bausch Health Companies, the average price target is $9.80. The highest price target for BHC is $14.00, while the lowest price target for BHC is $7.00. The average price target represents a forecasted upside of 63.61% from the current price of $5.99.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	0 Buy rating(s)
Hold	4 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$9.80	$11.33	$12.50	$8.17
Forecasted Upside	63.61% Upside	31.53% Upside	46.54% Upside	-0.16% Downside

Get Bausch Health Companies Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto 101 Media

Next opportunity for crypto millions

The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…

Check out the new "Crypto Bull Run Millionaire Blueprint" now!

BHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bausch Health Companies Stock vs. The Competition

Type	Bausch Health Companies	Medical Companies	S&P 500
Consensus Rating Score	2.20	2.72	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	63.33% Upside	2,848.63% Upside	9.14% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/25/2024	Truist Financial 1 of 5 stars		Lower Target	Hold ➝ Hold	$8.00 ➝ $7.00	+18.85%
7/10/2024	Raymond James 4 of 5 stars	G. Nachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform	$8.00	+11.19%
4/29/2024	Piper Sandler 2 of 5 stars		Boost Target	Neutral	$7.00 ➝ $9.00	+2.39%
4/23/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Perform ➝ Sector Perform	$12.00 ➝ $11.00	+29.72%
2/20/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$16.00 ➝ $14.00	+63.17%
6/16/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
7/28/2022	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Schott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:22 AM ET.

BHC Forecast - Frequently Asked Questions

What is Bausch Health Companies' forecast for 2024?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Bausch Health Companies is $9.80, with a high forecast of $14.00 and a low forecast of $7.00.
Should I buy or sell Bausch Health Companies stock right now?: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.
Does Bausch Health Companies's stock price have much upside?: According to analysts, Bausch Health Companies's stock has a predicted upside of 25.85% based on their 12-month stock forecasts.
What analysts cover Bausch Health Companies?: Bausch Health Companies has been rated by research analysts at Piper Sandler, Raymond James, and Truist Financial in the past 90 days.
Do Wall Street analysts like Bausch Health Companies more than its competitors?: Analysts like Bausch Health Companies less than other "medical" companies. The consensus rating for Bausch Health Companies is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BHC compares to other companies.